Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

计划入组 38 人 · 首次发布于 2015 年 2 月 3 日

An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)

计划入组 503 人 · 首次发布于 2012 年 5 月 23 日

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

计划入组 37 人 · 首次发布于 2018 年 3 月 16 日

small molecule therapeutic (basal cell carcinoma)

Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine (Vero Cell),Inactivated

renal cell carcinoma program

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Inhibitor Therapeutics Advances Itraconazole for Gorlin Syndrome, Reports 0.265 New Surgically Eligible BCCs Per Patient-Year

Inhibitor Therapeutics Advances Itraconazole Program for Gorlin Syndrome with Novel Amorphous Formulation

Medicus Pharma Completes Phase 2 Enrollment for Novel Microneedle Basal Cell Carcinoma Treatment